Skip to main content

Table 4 Associations between liver fibrosis indices and substantial HE in patients within 6 h of onset (n = 200)

From: Liver fibrosis indices associated with substantial hematoma expansion in Chinese patients with primary intracerebral hemorrhage

Index

Odds ratio (95% confidence interval); p-value

Model 1

Model 2

APRI

2.634 (1.299-5.341); p = 0.007

2.641 (1.303-5.356); p = 0.007

AARPRI

1.526 (1.081-2.156); p = 0.016

1.553 (1.093-2.207); p = 0.014

FIB-4

1.336 (1.071-1.667); p = 0.010

1.345 (1.077-1.679); p = 0.009

mFIB-4

1.084 (1.003-1.170); p = 0.041

1.088 (1.006-1.177); p = 0.034

FibroQ

1.076 (1.001-1.156); p = 0.048

1.080 (1.003-1.163); p = 0.042

Forns index

1.365 (1.104-1.689); p = 0.004

1.366 (1.104-1.689); p = 0.004

  1. Abbreviations: APRI AST-platelet ratio index, AARPRI AAR/platelet ratio index, where AAR is aspartate aminotransferase/alanine aminotransferase (AST/ALT) ratio, FIB-4 fibrosis-4, mFIB-4 modified fibrosis-4, FibroQ fibrosis quotient, ICH intracerebral hemorrhage, CI confidence interval
  2. Model 1 was adjusted for age, sex and hematoma location
  3. Model 2 was adjusted for the same variables as Model 1, as well as baseline hematoma volume